Latest news
Specialty Drug Costs Expected To Jump 32% By 2028, PSG Finds - Word & Brown General AgencyWord & Brown General Agency · Thu, 06 Aug 2026 19:55:55 GMTFAQ: Inside Pharma’s Changing Hub Landscape - Pharmaceutical CommercePharmaceutical Commerce · Thu, 06 Aug 2026 13:06:55 GMTIs Knight Therapeutics (TSX:GUD) Redefining Canada’s Specialty Pharma Landscape? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 21:20:00 GMTAscellaHealth Delivers Mid-Year Specialty Pharmacy Outlook to Help Payers Navigate Pipeline Innovation, Cost and Benefit Strategy - markets.businessinsider.commarkets.businessinsider.com · Fri, 31 Jul 2026 02:46:16 GMT